Loading
EMA news and CHMP meeting highlights
The EMA's CHMP highlights show Europe's approval pipeline one month ahead of European Commission decisions.
Overview
The EMA news pages and CHMP meeting highlights hold the monthly CHMP opinions: new medicines recommended, indication extensions and negative opinions. They show Europe's approval pipeline about one month ahead of the European Commission decisions. The highlights are published on the Friday of each CHMP week by the European Medicines Agency and are public. They are best read alongside the FDA OCE approval notifications to see where US and EU decisions diverge. On OnCo the source is tagged source and data, and the institution record European Medicines Agency links to it.
Holds
Monthly CHMP opinions: new medicines recommended, indication extensions, negative opinions.
Licence
Public
Maintainer
European Medicines Agency
Connected
2Similar pages
- CollectionDimensions
Shares the tags source, data.
- CollectionNICE technology appraisals
Shares the tags source, data.
- CollectionSemantic Scholar
Shares the tags source, data.
- IdeaDrop the extra switching studies for interchangeable oncology biosimilars
Shares European Medicines Agency, FDA Oncology Center of Excellence.
- CollectionEvaluate Vantage
Shares the tags source, data.
- InstitutionComisión Federal para la Protección contra Riesgos Sanitarios
Shares European Medicines Agency, FDA Oncology Center of Excellence.
- InstitutionSwissmedic
Shares European Medicines Agency, FDA Oncology Center of Excellence.
- TermExpanded access (compassionate use)
Shares European Medicines Agency, FDA Oncology Center of Excellence.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
European Medicines Agency · 1
A source that has moved or gone is reported by the weekly link check. /audit/